BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26232077)

  • 1. Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains.
    Saia-Cereda VM; Cassoli JS; Schmitt A; Falkai P; Nascimento JM; Martins-de-Souza D
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):601-12. PubMed ID: 26232077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential proteome and phosphoproteome may impact cell signaling in the corpus callosum of schizophrenia patients.
    Saia-Cereda VM; Cassoli JS; Schmitt A; Falkai P; Martins-de-Souza D
    Schizophr Res; 2016 Nov; 177(1-3):70-77. PubMed ID: 27094720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients.
    Café-Mendes CC; Ferro ES; Torrão AS; Crunfli F; Rioli V; Schmitt A; Falkai P; Britto LR; Turck CW; Martins-de-Souza D
    J Proteomics; 2017 Jan; 151():97-105. PubMed ID: 27321914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum.
    Steiner J; Schmitt A; Schroeter ML; Bogerts B; Falkai P; Turck CW; Martins-de-Souza D
    Eur Arch Psychiatry Clin Neurosci; 2014 Jun; 264(4):311-6. PubMed ID: 24504531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia.
    Pinacho R; Villalmanzo N; Meana JJ; Ferrer I; Berengueras A; Haro JM; Villén J; Ramos B
    Schizophr Res; 2016 Nov; 177(1-3):88-97. PubMed ID: 27236410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics of the corpus callosum to identify novel factors involved in hypomyelinated Niemann-Pick Type C disease mice.
    Yang F; Guan Y; Feng X; Rolfs A; Schlüter H; Luo J
    Mol Brain; 2019 Mar; 12(1):17. PubMed ID: 30866987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
    Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
    J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model.
    Wesseling H; Want EJ; Guest PC; Rahmoune H; Holmes E; Bahn S
    J Proteome Res; 2015 Aug; 14(8):3174-87. PubMed ID: 26043028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia.
    Martins-de-Souza D; Maccarrone G; Wobrock T; Zerr I; Gormanns P; Reckow S; Falkai P; Schmitt A; Turck CW
    J Psychiatr Res; 2010 Dec; 44(16):1176-89. PubMed ID: 20471030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the human brain myelin proteome and differences associated with schizophrenia.
    Martins-de-Souza D; Guest PC; Reis-de-Oliveira G; Schmitt A; Falkai P; Turck CW
    World J Biol Psychiatry; 2021 Apr; 22(4):271-287. PubMed ID: 32602824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential protein expression in the corpus callosum (splenium) of human alcoholics: a proteomics study.
    Kashem MA; James G; Harper C; Wilce P; Matsumoto I
    Neurochem Int; 2007 Jan; 50(2):450-9. PubMed ID: 17141922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the human brain proteome: characterization of the anterior temporal lobe and corpus callosum as part of the Chromosome 15-centric Human Proteome Project.
    Martins-de-Souza D; Carvalho PC; Schmitt A; Junqueira M; Nogueira FC; Turck CW; Domont GB
    J Proteome Res; 2014 Jan; 13(1):147-57. PubMed ID: 24274931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXXC5 plays a role as a transcription activator for myelin genes on oligodendrocyte differentiation.
    Kim MY; Kim HY; Hong J; Kim D; Lee H; Cheong E; Lee Y; Roth J; Kim DG; Min do S; Choi KY
    Glia; 2016 Mar; 64(3):350-62. PubMed ID: 26462610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human myelin proteome and comparative analysis with mouse myelin.
    Ishii A; Dutta R; Wark GM; Hwang SI; Han DK; Trapp BD; Pfeiffer SE; Bansal R
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14605-10. PubMed ID: 19706548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential epithelial and stromal protein profiles in keratoconus and normal human corneas.
    Joseph R; Srivastava OP; Pfister RR
    Exp Eye Res; 2011 Apr; 92(4):282-98. PubMed ID: 21281627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis.
    Martins-de-Souza D; Gattaz WF; Schmitt A; Rewerts C; Marangoni S; Novello JC; Maccarrone G; Turck CW; Dias-Neto E
    J Neural Transm (Vienna); 2009 Mar; 116(3):275-89. PubMed ID: 19034380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropathological study of myelin oligodendrocyte glycoprotein in the temporal lobe of schizophrenia patients.
    Marui T; Torii Y; Iritani S; Sekiguchi H; Habuchi C; Fujishiro H; Oshima K; Niizato K; Hayashida S; Masaki K; Kira J; Ozaki N
    Acta Neuropsychiatr; 2018 Aug; 30(4):232-240. PubMed ID: 29564992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
    Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
    Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.